Elsevier

Clinics in Dermatology

Volume 28, Issue 4, July–August 2010, Pages 440-451
Clinics in Dermatology

Healing fats of the skin: the structural and immunologic roles of the ω-6 and ω-3 fatty acids

https://doi.org/10.1016/j.clindermatol.2010.03.020Get rights and content

Abstract

Linoleic acid (18:2ω6) and α-linolenic acid (18:3ω3) represent the parent fats of the two main classes of polyunsaturated fatty acids: the ω-6 (n-6) and the ω-3 (n-3) fatty acids, respectively. Linoleic acid and α-linolenic acid both give rise to other long-chain fatty acid derivatives, including γ-linolenic acid and arachidonic acid (ω-6 fatty acids) and docosahexaenoic acid and eicosapentaenoic acid (ω-3 fatty acids). These fatty acids are showing promise as safe adjunctive treatments for many skin disorders, including atopic dermatitis, psoriasis, acne vulgaris, systemic lupus erythematosus, nonmelanoma skin cancer, and melanoma. Their roles are diverse and include maintenance of the stratum corneum permeability barrier, maturation and differentiation of the stratum corneum, formation and secretion of lamellar bodies, inhibition of proinflammatory eicosanoids, elevation of the sunburn threshold, inhibition of proinflammatory cytokines (tumor necrosis factor-α, interferon-γ, and interleukin-12), inhibition of lipoxygenase, promotion of wound healing, and promotion of apoptosis in malignant cells, including melanoma. They fulfill these functions independently and through the modulation of peroxisome proliferator-activated receptors and Toll-like receptors.

Introduction

Interest in the use of dietary fats to treat skin disease is marked by the historic study of Burr and Burr in 1929,1, 2 where rats fed a diet devoid of all fat experienced growth retardation, reproductive failure, and a scaling erythematous skin eruption with increased transepidermal water loss. Clinical manifestations diminished when the diet was supplemented with linoleic and α-linolenic acids. Similarly, one of the investigators from these early experiments found he could rid his hand dermatitis by consuming these polyunsaturated fatty acids (PUFAs). Originally referred to as vitamin F, these fats soon came to be known as the essential fatty acids (EFAs), because humans lack the enzymes necessary for their synthesis.

These original works, as well as other early studies, have been criticized because a distinction was not drawn between supplementation with ω-6 (linoleic acid) or ω-3 (α-linolenic) fatty acids.3 Differentiating between the two is important, because their roles, as we have now come to understand more clearly, are distinct—linoleic acid and its products serve as structural precursors for the important stratum corneum ceramides, and α-linolenic derivatives serve as immune modulators. We have just begun to recognize the sophisticated contribution of the PUFAs in skin disease through these and other structural and immunologic roles.

As we shall discuss, linoleic acid (LA) and its derivatives play a central role in the structure and function of the stratum corneum permeability barrier, defects of which are most notable in atopic dermatitis. Derivatives of α-linolenic acid (ALA) can modulate the immune response of the epidermis by influencing T lymphocytes, acting on Toll-like receptors (TLRs), and activating caspase cascades that influence many inflammatory dermatoses, including acne vulgaris, psoriasis, atopic dermatitis, systemic lupus erythematosus, and skin cancer. Finally, the ω-3s are ligands for an important class of transcription factors, the peroxisome proliferator-activated receptors (PPARs), which are important in lipid metabolism, sugar homeostasis, and insulin sensitization as well as inflammation, immune regulation, and skin barrier homeostasis. They also show promise as natural options for treating inflammatory skin disease and skin carcinogenesis, including melanoma.

Section snippets

PUFA terminology, metabolism and dietary homeostasis

LA (18:2ω6) and ALA (18:3ω3) represent the parent fats of the two main classes of PUFAs: the ω-6 (n-6) and the ω-3 (n-3) fatty acids, respectively. LA and ALA both give rise to other long-chain fatty acid derivatives and a host of other lipid mediators, including prostaglandins, leukotrienes, and lipoxins by way of a shared set of enzymes (Figure 1).

LA is found in the oils of safflower, grape seed, poppy seed, sunflower, hemp, corn, wheat germ, cottonseed, and soybean. Many of these oils are

LA and the stratum corneum permeability barrier

LA is the most abundant fatty acid in the epidermis. Importantly, it is also the precursor to ceramides, a major component of the extracellular lipid matrix that forms the stratum corneum permeability barrier (SCPB). There are essentially three components of the SCPB: the extracellular lipid matrix, the cornified envelop, and dense keratin fibrils aggregated by filaggrin. The extracellular lipid matrix is composed of 50% ceramides, 25% cholesterol, and 15% free fatty acids.9 Lipids, enzymes,

Immune-modulating roles of ω-3 fatty acids in the epidermis and skin disease

DHA and EPA are not major constituents of the epidermis, which is likely a reflection of insufficient dietary consumption or increased cellular utilization. Unlike LA, which plays a major structural role in the epidermis and SCPB, ω-3 fatty acids appear to play an immune-modulating role. EPA has been shown to reduce the expression of intercellular adhesion molecule-1,59 reduce T-lymphocyte proliferation, and dampen delayed-type hypersensitivity.60 Diets supplemented with fish oil can lead to

Introduction to the PPARs

Ligands for the PPARs are emerging as valuable treatments for many diseases, including skin disease. DHA and EPA are natural ligands for these receptors. Synthetic ligands, such as the thiazolidinediones, have been used in psoriasis with success.85 There are three PPAR isoforms: PPAR-α, PPAR-β/Δ, and PPAR-γ. They are members of the nuclear receptor family that partner with the retinoic acid X receptor to fulfill their functions. Their primary role has been in cardiovascular medicine and

TLRs and ω-3 fatty acids

The TLRs are a fairly recently identified group of receptors that are present on many cells, including keratinocytes, monocytes, Langerhans cells, dermal dendritic cells, and intestinal epithelial cells. The TLRs are involved in the first-line recognition of pathogens. They are pattern-recognition receptors that recognize certain pathogen-associated molecular patterns expressed by microbes. TLRs communicate signals of tolerance from recognized commensals or, when danger is sensed, elicit

Conclusions

The mechanisms of the nutritional deficiency dermatosis originally recognized by Burr and Burr1, 2 are becoming more fully understood as the diverse and elaborate roles of the PUFAs are elucidated. Furthermore, PUFAs are proving to be essential to healthy skin and aid in the healing of diseased skin.

A fatty acid profile can help identify patients with suboptimal fatty acid concentrations. Absolute fatty acid concentrations, ω-6:ω-3 ratios, and mead acid levels—a marker of essential fatty acid

References (134)

  • Ekanayake-MudiyanselageS. et al.

    Expression of epidermal keratins and the cornified envelop protein involucrin is influenced by permeability barrier disruption

    J Invest Dermatol

    (1998)
  • SchurerN.Y. et al.

    Evidence for a novel keratinocyte fatty acid uptake mechanism with preference for linoleic acid: comparison of oleic acid and linoleic acid uptake by cultured human keratinocytes, fibroblasts and a human hepatoma cell line

    Biochin Biophys Acta

    (1994)
  • EliasP.M. et al.

    Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms

    J Allergy Clin Immunol

    (2008)
  • ProkschE. et al.

    Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis

    J Invest Dermatol

    (1992)
  • UchidaY. et al.

    Vitamin C stimulates sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures

    J Invest Dermatol

    (2001)
  • HowellM.D. et al.

    Cytokine modulation of atopic dermatitis filaggrin skin expression

    J Allergy Clin Immunol

    (2009)
  • EliasS.L. et al.

    Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length

    Am J Clin Nutr

    (2001)
  • HorrobinD.F.

    Essential fatty acid metabolism and its modification in atopic eczema

    Am J Clin Nutr

    (2000)
  • OkinoN. et al.

    Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa

    J Biol Chem

    (1998)
  • JacksonS.M. et al.

    Effect of cutaneous permeability barrier on HMG CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice

    J Lipid Res

    (1992)
  • HarrisI.R. et al.

    Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis

    J Invest Dermatol

    (1997)
  • OtteyK.A. et al.

    Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice

    J Invest Dermatol

    (1995)
  • FeingoldK.R.

    The role of epidermal lipids in cutaneous permeability barrier homeostasis

    J Lipid Res

    (2007)
  • BleckB. et al.

    Cloning and chromosomal localisation of the murine epidermal-type fatty acid binding protein gene (Fabpe)

    Gene

    (1998)
  • MadsenP. et al.

    Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated faty acid-binding protein [PA-FABP] that is highly upregulated in psoriatic skin and that shares similarity to fatty acid-binding proteins

    J Invest Dermatol

    (1992)
  • SiegenthalerG. et al.

    Characterization and expression of a novel fatty acid-binding protein: the epidermal type (E-FABP)

    Biochem Biophys Res Commun

    (1993)
  • HughesD.A. et al.

    Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes

    Am J Clin Nutr

    (1996)
  • KelleyD.S. et al.

    Dietary alpha-linoleic acid and immunocompetence in humans

    Am J Clin Nutr

    (1991)
  • MillerC.C. et al.

    Dietary supplementation with n-3 and n-6 enriched oils influences in vivo levels of epidermal lipoxygenase products

    J Nutr

    (1990)
  • MillerC.C. et al.

    Dietary supplementation with ethyl ester concentrations of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative antiinflammatory metabolites

    J Invest Dermatol

    (1991)
  • FoghK. et al.

    Eicosanoids in acute and chronic psoriatic lesions: Leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions

    J Invest Dermatol

    (1989)
  • BlackA.K. et al.

    Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis

    J Invest Dermatol

    (1990)
  • GdalevichM. et al.

    Breastfeeding and the onset of atopic dermatitis in childhood: A systematic review and meta-analysis of prospective studies

    J Am Acad Dermatol

    (2001)
  • MayserP. et al.

    Omega-3 fatty acid-bsed lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial

    J Am Acad Dermatol

    (1998)
  • BiondoP.D. et al.

    The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy

    J Nutr Biochem

    (2008)
  • MohanI.K. et al.

    Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus

    Prostaglandins Leukot Essent Fatty Acids

    (1997)
  • DreyerC. et al.

    Control of the peroxisome beta-oxidation pathway by a novel family of nuclear hormone receptors

    Cell

    (1992)
  • Vu-DacN. et al.

    Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element

    J Biol Chem

    (1994)
  • HertzR. et al.

    Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III

    J Biol Chem

    (1995)
  • RodriguezJ.C. et al.

    Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids

    J Biol Chem

    (1994)
  • LeibowitzM.D. et al.

    Activation of PPARdelta alters lipid metabolism in db/db mice

    FEBS Lett

    (2000)
  • MartinH.

    Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components

    Mutat Res

    (2009)
  • FaveeuwC. et al.

    Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells

    FEBS Lett

    (2000)
  • WestergaardM. et al.

    Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin

    J Invest Dermatol

    (2003)
  • DasU.N.A.

    Perinatal strategy for preventing adult diseases: the role of long-chain polyunsaturated fatty aids

    (2002)
  • OllisT.E. et al.

    Australian food sources and intakes of omega-6 and omega-3 polyunsaturated fatty acids

    Ann Nutr Metab

    (1999)
  • DasU.N.

    Essential fatty acids: biochemistry, physiology and pathology

    Biotech J

    (2006)
  • WertzP.W.

    Biochemistry of human stratum corneum lipids

  • EliasP. et al.

    Epidermal lamellar body as a multifunctional secretory organelle

  • AkiyamaM. et al.

    Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer

    J Clin Invest

    (2005)
  • Cited by (0)

    View full text